Genomics

Dataset Information

0

A Phase II Neoadjuvant Study of Palbociclib in Combination with Letrozole and Trastuzumab as Neoadjuvant Treatment of Stage II-III ER+ HER2+ Breast Cancer (PALTAN)


ABSTRACT: A Phase II Neoadjuvant Study of Palbociclib in Combination with Letrozole and Trastuzumab as Neoadjuvant Treatment of Stage II-III ER+ HER2+ Breast Cancer (PALTAN)

PROVIDER: PRJNA909911 | ENA |

REPOSITORIES: ENA

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1